In this program, we review a patient case to understand the intensification of therapy beyond metformin
This Self-Learning program has been certified by the College of Family Physicians of Canada for up to
Cert+ Program ID#:
| David C.W. Lau(MD, PhD, FRCPC) David Strain(MB, ChB, BSc (Hons) MD, FRCP) Deanna Telner(MD, CCFP) Elizabeth Rosolowsky(MD, MPH, FAAP, FRCPC) Filip K. Knop(MD, PhD) Jeffrey Habert(MD, CCFP, FCFP) John Axler(MD, CCFP, FCFP) Peter J. Lin(MD, CCFP) Robyn L. Houlden(MD, FRCPC) Thomas Round(MBBS, BSc, DRCOG, MRCGP) |
Upon completion of this program, participants will be able to:
- Review the key considerations for selecting an antihyperglycemic agent after metformin therapy
- Examine the impact of cardiovascular disease and patient preference on antihyperglycemic agent selection